Danske Bank A S Buys Shares of 890,499 CVS Health Corporation $CVS

Key Points

• Danske Bank acquired 890,499 CVS Health shares worth approximately $92.1 million, representing about 0.07% of the company. Institutional investors collectively own 80.66% of CVS.
• CVS reported strong quarterly results, with EPS of $2.58 versus the $1.87 consensus estimate and revenue of $106.1 billion, up 7.3% year over year. The company also raised its 2026 adjusted operating-income outlook.
• Analysts remain bullish, with a consensus “Moderate Buy” rating and an average price target of $106.75; CVS recently paid a quarterly dividend of $0.665, implying a 2.8% annualized yield.

Danske Bank A S purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 890,499 shares of the pharmacy operator's stock, valued at approximately $92,122,000. Danske Bank A S owned about 0.07% of CVS Health as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of CVS. BlackRock Inc. bought a new stake in CVS Health in the 2nd quarter valued at $12,747,462,000. Norges Bank acquired a new position in shares of CVS Health during the fourth quarter valued at about $1,666,265,000. Wellington Management Group LLP lifted its stake in shares of CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator's stock valued at $1,473,270,000 after buying an additional 12,233,675 shares during the period. Pzena Investment Management LLC acquired a new stake in CVS Health during the second quarter worth about $1,217,558,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of CVS Health during the second quarter valued at approximately $932,454,000. Institutional investors own 80.66% of the company's stock.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS reported strong second-quarter results, with earnings per share rising more than 40% year over year as profitability in its Health Care Benefits segment improved. The company also raised its 2026 adjusted operating income outlook, reinforcing the recovery story. CVS Q2 EPS Gains From Improved Health Care Benefits Profitability
• Positive Sentiment: CVS appointed Teresa Heitsenrether, JPMorgan’s data and analytics chief, to its board. Her technology, analytics and operating experience could support CVS’s artificial-intelligence and data initiatives, potentially improving efficiency and decision-making across its businesses. CVS adds JPMorgan data executive to board amid AI push
• Positive Sentiment: Brokerages assigned CVS an average “Moderate Buy” rating, reflecting improved earnings momentum and optimism about Aetna’s performance. CVS Health Given Average Rating of Moderate Buy

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CVS shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of CVS Health from $88.00 to $92.00 and gave the company a "buy" rating in a research note on Thursday, May 7th. Piper Sandler restated an "overweight" rating and issued a $113.00 target price on shares of CVS Health in a research note on Monday, June 1st. Mizuho lifted their price target on CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a report on Monday, June 8th. Truist Financial upped their price target on shares of CVS Health from $108.00 to $118.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Finally, Wall Street Zen upgraded shares of CVS Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 8th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $106.75.

Insider Activity at CVS Health

In other news, Director Larry Robbins sold 370,462 shares of CVS Health stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the sale, the director owned 4,824,799 shares in the company, valued at $450,877,466.55. The trade was a 7.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.85% of the stock is currently owned by corporate insiders.

CVS Health Trading Up 0.9%

CVS stock opened at $94.87 on Wednesday. The company has a market cap of $121.33 billion, a P/E ratio of 25.10, a PEG ratio of 0.93 and a beta of 0.61. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The business has a fifty day moving average of $102.41 and a 200-day moving average of $88.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's dividend payout ratio (DPR) is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source